http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10322129-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ace8ed41c2a7ed306d657b7b7de64d9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb47dc59f3609dcf835d160b2a1528bb
publicationDate 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10322129-B2
titleOfInvention Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same
abstract A method comprising: (a) identifying a subject in need of treatment for cataract and/or nevus and/or tumor lesion; and (b) topically administering to the eye an amount of dipyridamole which is physiologically effective in treatment of cataract and/or nevus and/or melanoma.
priorityDate 2015-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007225217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6300328-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9254289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0011654-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0234854-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5731432-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3031450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4912092-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008122978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5780450-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007010502-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010222369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825102-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4382953-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5438060-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2170

Total number of triples: 56.